Prognostic methylation markers for overall survival in cytogenetically normal AML patients treated on SWOG trials

BACKGROUND: Aberrant DNA methylation is known to occur in acute myeloid leukemia (AML), while methylation signatures and prognostic markers have been proposed. This study aimed to evaluate all CpG sites of the genome and identify prognostic methylation markers for overall survival in AML patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Qu, Xiaoyu, Othus, Megan, Davison, Jerry, Wu, Yu, Yan, Liying, Meshinchi, Soheil, Ostronoff, Fabiana, Estey, Elihu, Radich, Jerry, Erba, Harry, Appelbaum, Frederick R., Fang, Min
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5705230/
https://ncbi.nlm.nih.gov/pubmed/28222251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30626
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados